Back

Procedural volume and outcomes in patients with cardiogenic shock who received Impella: insight from the J-PVAD Registry

31 August 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Optimising the management of cardiogenic shock Cardiogenic Shock ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yuji Nishimoto

Toyonaka Municipal Hospital, Toyonaka (Japan)

8 More presentations in this session

Presentation thumbnail
Diastolic shock index: a novel prognostic parameter unveiling insights into vasodilatory cardiogenic shock
Doctor M. Paiva (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Mechanical right ventricular involvement is independent of right coronary arterial bed and has a prognostic impact in acute myocardial infarction complicated by cardiogenic shock.
Doctor R. Espinosa-Soto (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Cardiogenic shock is more prevalent in racialised and newcomer populations and associated with higher mortality
Doctor D. Brahmbhatt (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Association between cardiogenic shock phenotype, vasopressor requirements and mortality
Doctor D. Sarma (Nashville, US)
Abstract Slides Video
Presentation thumbnail
Timing of inopressor initiation in patients with acute myocardial infarction complicated by cardiogenic shock
Mrs S. Ten Berg (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Optimising the management of cardiogenic shock

The Event

Event poster

ESC Congress 2024

31 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Short-term outcomes of impella support in japanese patients with cardiogenic shock due to non-ischemic cardiomyopathy
thumbnail
Congress Presentation
Volume-outcome relationships for intra-aortic balloon pump in acute myocardial infarction
thumbnail
Congress Presentation
Centralization of CS care and MCS use

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources